CompletedNCT00314184
Quetiapine or lithium for long-term bipolarity maintenance
About this title
Read the official source — NCT00314184This study evaluated the safety and effectiveness of quetiapine fumarate for people with bipolarity.
Medication studyAges 18+Multiple countries
Understand this study
What did researchers investigate?
This study evaluated the safety and effectiveness of quetiapine fumarate for people with bipolarity.
Who was this study for?
This study was for people with bipolarity. Listed age limits: from 18 years. Other eligibility criteria applied.
- Listed locations
- Cerritos and 94 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateMarch 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 1,255
- Sponsor
- AstraZeneca
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States, Argentina, Bulgaria, ...
- Age range
- Over 18 Years
- Official registry ID
- NCT00314184
- Official title
Show the full official title
Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Phase 3 Study of the Efficacy and Safety of Quetiapine Fumarate and Lithium as Monotherapy for up to 104 Weeks Maintenance Treatment of Bipolar I Disorder in Adult Patients
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Cerritos, United States · San Diego, United States · Santa Ana, United States
93 more locations
- Washington D.C., United States
- Gainesville, United States
- Jacksonville, United States
- North Miami, United States
- Orlando, United States
- Atlanta, United States
- Eagle, United States
- Hoffman Estates, United States
- Terre Haute, United States
- Shreveport, United States
- Flowood, United States
- Saint Charles, United States
- Las Vegas, United States
- Clementon, United States
- Rochester, United States
- Raleigh, United States
- Fargo, United States
- Portland, United States
- Salem, United States
- Philadelphia, United States
- Memphis, United States
- Austin, United States
- Lake Jackson, United States
- Richmond, United States
- Bellevue, United States
- Kirkland, United States
- Seattle, United States
- Capital Federal, Argentina
- Córdoba, Argentina
- La Plata, Argentina
- Lanus, Argentina
- Mendoza, Argentina
- Rosario, Argentina
- Burgas, Bulgaria
- Plovdiv, Bulgaria
- Sofia, Bulgaria
- Antioquia, Colombia
- Barranquilla, Colombia
- Bogotá, Colombia
- Pereira, Colombia
- Ahmedabad, India
- Chennai, India
- Jaipur, India
- Kanpur, India
- Lucknow, India
- Mangalore, India
- Manipal, India
- Mumbai, India
- New Delhi, India
- Visakhapatnam, India
- Kaunas, Lithuania
- Klaipėda, Lithuania
- Vilnius, Lithuania
- Kuala Lumpur, Malaysia
- Sarawak, Malaysia
- León, Mexico
- México, Mexico
- San Luis Potosí City, Mexico
- Lima, Peru
- Cebu City, Philippines
- Davao City, Philippines
- Mandaluyong, Philippines
- Manila, Philippines
- Quezon City, Philippines
- Arad, Romania
- Brasov, Romania
- Bucharest, Romania
- Cluj-Napoca, Romania
- Com Jebel, Romania
- Craiova, Romania
- Iași, Romania
- Oradea, Romania
- Piteşti, Romania
- Sibiu, Romania
- Targoviste, Romania
- Târgu Mureş, Romania
- Kazan', Russia
- Moscow, Russia
- Saint Petersburg, Russia
- Kaohsiung Hsien, Taiwan
- Taipei, Taiwan
- Taoyuan City, Taiwan
- Taoyuan Hsien, Taiwan
- Bangkok, Thailand
- Dnipro, Ukraine
- Kharkiv, Ukraine
- Kiev, Ukraine
- Kyiv, Ukraine
- Lviv, Ukraine
- Odesa, Ukraine
- Simferopol, Ukraine
- Vinnitsa, Ukraine
- Russia
Interested in joining this study?
Questions about this study
What did researchers investigate?
This study evaluated the safety and effectiveness of quetiapine fumarate for people with bipolarity.
Who is behind this study?
The study sponsor is AstraZeneca.
Did this study involve medication?
Yes. The study involved medication, including quetiapine fumarate.
Who was this study for?
This study was for people with bipolarity. Listed age limits: from 18 years. Other eligibility criteria applied.
